A business venture between Gumlink A/S and Tab Labs Inc. has the leading gum developers has both companies staged for a growing nutraceutical gum market.
A business venture between two of the world’s leading gum developers has both companies staged for a growing nutraceutical gum market.
With manufacturing technologies, functional ingredients in chewing gum are becoming less of a pipe dream and more of a reality. Today, Gumlink A/S (Vejle, Denmark) announced that the European business-to-business developer of chewing gum has acquired 50% stake in Tab Labs Inc. (Vancouver), a North American developer of chewing gum technologies. This joining of forces is expected to speed up progress in the nutraceutical chewing gum market, namely related to probiotics.
At the same time, Dr. Chris Chilcott, known for his part in developing oral probiotic strains Blis K-12 and Blis M-18, is joining Tab Labs to head the company’s new Nutraceutical Innovation Center.
Gumlink CEO Soren Birn sums up his expectations of the new business venture:
This move makes perfect sense for us, as it will provide us with a nutraceutical manufacturing and distribution platform in North America and provide access to novel technologies that, when combined with our own proprietary gum technologies, will enable us to offer the most potent nutraceutical chewing gum assortment. Furthermore, Gumlink is now following our strategic pathway to maintain and further build our position as the world’s leading nutraceutical gum developer and manufacturer.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.